Apyx Medical Inc (NASDAQ:APYX) — Market Cap & Net Worth
Market Cap & Net Worth: Apyx Medical Inc (APYX)
Apyx Medical Inc (NASDAQ:APYX) has a market capitalization of $127.64 Million ($127.64 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18365 globally and #4291 in its home market, demonstrating a -0.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Apyx Medical Inc's stock price $3.03 by its total outstanding shares 42124023 (42.12 Million). Also see APYX total asset value for a full breakdown of the balance sheet.
Apyx Medical Inc Market Cap History: 2015 to 2026
Apyx Medical Inc's market capitalization history from 2015 to 2026. Data shows growth from $88.46 Million to $127.64 Million (3.88% CAGR). Also see APYX cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Apyx Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #514 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1788 of 3165 |
Weight: Apyx Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Apyx Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Apyx Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Apyx Medical Inc (APYX) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.79x
Apyx Medical Inc's market cap is 2.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $151.23 Million | $36.63 Million | -$3.95 Million | 4.13x | N/A |
| 2017 | $109.52 Million | $38.88 Million | -$5.06 Million | 2.82x | N/A |
| 2018 | $272.96 Million | $16.69 Million | $64.01 Million | 16.36x | 4.26x |
| 2019 | $356.37 Million | $28.23 Million | -$19.71 Million | 12.62x | N/A |
| 2020 | $303.29 Million | $27.71 Million | -$11.90 Million | 10.94x | N/A |
| 2021 | $540.03 Million | $48.52 Million | -$15.17 Million | 11.13x | N/A |
| 2022 | $98.57 Million | $44.51 Million | -$23.18 Million | 2.21x | N/A |
| 2023 | $110.36 Million | $52.35 Million | -$18.71 Million | 2.11x | N/A |
| 2024 | $66.56 Million | $48.10 Million | -$23.46 Million | 1.38x | N/A |
| 2025 | $147.43 Million | $52.84 Million | -$11.21 Million | 2.79x | N/A |
Competitor Companies of APYX by Market Capitalization
Companies near Apyx Medical Inc in the global market cap rankings as of September 18, 2026. Review Apyx Medical Inc tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Apyx Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Apyx Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Apyx Medical Inc's market cap moved from $88.46 Million to $ 127.64 Million, with a yearly change of 3.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $127.64 Million | -13.43% |
| 2025 | $147.43 Million | +121.52% |
| 2024 | $66.56 Million | -39.69% |
| 2023 | $110.36 Million | +11.97% |
| 2022 | $98.57 Million | -81.75% |
| 2021 | $540.03 Million | +78.06% |
| 2020 | $303.29 Million | -14.89% |
| 2019 | $356.37 Million | +30.56% |
| 2018 | $272.96 Million | +149.23% |
| 2017 | $109.52 Million | -27.58% |
| 2016 | $151.23 Million | +70.95% |
| 2015 | $88.46 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Apyx Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $127.64 Million USD |
| MoneyControl | $127.64 Million USD |
| MarketWatch | $127.64 Million USD |
| marketcap.company | $127.64 Million USD |
| Reuters | $127.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more